Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuse
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Degenerative Disc Disease
Conditions
Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis
Trial Timeline
Sep 1, 2009 → Jul 1, 2014
NCT ID
NCT00996073About Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuse
Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuse is a phase 2 stage product being developed by Mesoblast for Degenerative Disc Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00996073. Target conditions include Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis.
What happened to similar drugs?
1 of 6 similar drugs in Degenerative Disc Disease were approved
Approved (1) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00996073 | Phase 2 | Completed |
Competing Products
17 competing products in Degenerative Disc Disease